iBio (IBIO) Current Assets (2009 - 2026)
iBio (IBIO) posted Current Assets of $92.22 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 848.7% from $9.72 million a year earlier and up 19.3% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Current Assets (2009 - 2026) Analysis & Trends
Since fiscal Q4 2011, iBio has reported Current Assets for 61 quarters.
- Annual Current Assets shows a five-year compound annual growth rate of -2.5% (FY2021 to FY2026).
- In prior fiscal years, iBio's Current Assets was $9.72 million in FY2025 (-38.0%), $15.67 million in FY2024 (-40.3%), $26.26 million in FY2023 (-41.7%) and $45.07 million in FY2022 (-56.9%).
- The fiscal Q4 2026 figure stands as the highest quarterly Current Assets since fiscal Q4 2021.
- On a year-over-year basis, Current Assets increased in three of the last seven quarters, with growth averaging 214.0%.
- The strongest year-over-year quarter for Current Assets in the past five years was fiscal Q4 2026, with growth of 848.7%; the weakest was fiscal Q3 2025, with a decline of 83.1%.
- According to Business Quant data, Current Assets for the three prior fiscal quarters was $77.3 million (Q3 2026), $53.4 million (Q2 2026) and $50.8 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | iBio | 118.23 Mn | -174.02 Mn | - | 81.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 81.24 Mn |
| Jun 30, 2026 | 92.22 Mn |
| Mar 31, 2026 | 77.30 Mn |
| Dec 31, 2025 | 53.40 Mn |
| Sep 30, 2025 | 50.80 Mn |
| Jun 30, 2025 | 9.72 Mn |
| Mar 31, 2025 | 6.10 Mn |
| Dec 31, 2024 | 8.30 Mn |
| Sep 30, 2024 | 11.71 Mn |
| Jun 30, 2024 | 15.67 Mn |
| Mar 31, 2024 | 36.14 Mn |
| Dec 31, 2023 | 19.70 Mn |
| Sep 30, 2023 | 23.02 Mn |
| Jun 30, 2023 | 26.26 Mn |
| Mar 31, 2023 | 27.09 Mn |
| Dec 31, 2022 | 38.24 Mn |
| Sep 30, 2022 | 63.57 Mn |
| Jun 30, 2022 | 45.07 Mn |
| Mar 31, 2022 | 60.32 Mn |
| Dec 31, 2021 | 67.50 Mn |
API Access
iBio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();